Cardiac iPSCs for Drug Discovery

Video   Apr 27, 2016

 

Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field.

 
Company Information
 
 
 

Recommended Videos

The new Gibco™ One Shot™ FBS 50 mL bottle. Finally…Aliquot-free solution that reduces contamination.

Video

The Gibco One Shot FBS 50 mL bottle is designed to significantly improve your results and solve myriad challenges slowing down your research. Join the aliquot-free revolution today!

WATCH NOW

The First IVF Baby

Video

The development of in vitro fertilisation, or IVF, culminating in the ‘miraculous’ birth of Louise Joy Brown on 25 July 1978, was a defining moment for reproductive technology pioneered by British researchers.

WATCH NOW

CellStream™ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStream™ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy